Compare M & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | M | MMED |
|---|---|---|
| Founded | 1830 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.7B |
| IPO Year | 2003 | 2025 |
| Metric | M | MMED |
|---|---|---|
| Price | $23.08 | $23.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $20.09 | ★ $22.56 |
| AVG Volume (30 Days) | ★ 4.8M | 1.6M |
| Earning Date | 05-27-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | ★ 12.08 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $22,621,000,000.00 | $3,102,000,000.00 |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | $97.28 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $16.41 | $10.65 |
| 52 Week High | $26.59 | $24.43 |
| Indicator | M | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 41.22 | 76.98 |
| Support Level | $22.06 | $10.68 |
| Resistance Level | $22.92 | N/A |
| Average True Range (ATR) | 0.62 | 1.12 |
| MACD | -0.10 | 0.29 |
| Stochastic Oscillator | 31.85 | 91.13 |
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.